Business
MedMira's HIV/Hepatitis C Rapid Test Selected by Centers for Disease Control and Prevention (CDC) for Collaborative Evaluation Program
HALIFAX, June 9 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a developer ...
About this update from Medmira Inc.
[{"type":"text","content":"\n\n\n\nHALIFAX, June 9 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,\nNASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and\nsolutions, announced today that the Centers for Disease Control and Prevention\n(CDC) in the United States has selected the Company's Multiplo HIV/Hepatitis C\n(HCV) Rapid Test to be a part of a program entitled "Opportunity to\nCollaborate in the Evaluation of Rapid Diagnostic Tests for HIV and HCV".\n\n\nThis program of the National Center for HIV/AIDS, Viral Hepatitis, STD,\nand TB Prevention (NCHHSTP) at the Centers for Disease Control and Prevention\n(CDC) of the Department of Health and Human Services (DHHS) will see\nevaluations done in laboratories and in the field to determine the viability\nof rapid tests for use in screening and/or diagnosis of HIV and HCV in the\nUnited States. A number of rapid tests will be evaluated as part of the\nprogram however Multiplo HIV/HCV will be the only combination rapid\nflow-through test with the ability to deliver simultaneous results for HIV and\nHCV.\n\n\n"We are very pleased that our Multiplo HIV/HCV test was selected for\nevaluation in this important CDC program. International evaluations and\nfeedback from leading researchers have been very positive and we fully expect\nthat our proven technology platform will continue to exceed expectations as\npart of this program," said Hermes Chan, CEO of MedMira Inc. "In today's\neconomy, where every healthcare budget is being closely scrutinized, a\nmultiple test makes the most sense. Multiplo is essentially a 2-in-1 test that\ncosts the healthcare provider less while delivering results faster than any\ntwo single tests combined. It is a win-win for healthcare providers and their\npatients."\n\n\nAccording to the CDC's latest reports, an estimated 1,106,400 people in\nthe United States are living with HIV, with approximately 21% unaware of their\nstatus. Approximately 3.2 million persons in the United States have chronic\nhepatitis C virus infection. About one quarter of HIV-infected persons in the\nUnited States are also infected with hepatitis C virus.\n\n\nChan continued," It is widely understood that more testing and more\npeople knowing their status significantly decreases the spread of diseases\nlike HIV and Hepatitis C. Multiplo simulta...